Why the study?
Frailty significantly affects prognosis and quality of life in HF, but there is no consensus on the best method to assess it in daily practice.
Frailty is highly prevalent in heart failure patients and significantly worsens prognosis, necessitating routine multidimensional assessment and tailored management.
Answers are grounded in this paper and cite their sources.
HF patients warrant frailty assessment regardless of age; no consensus on instruments leaves open standardization in care and research.
The importance of frailty in heart failure (HF) patients has been increasingly recognized because of its high prevalence and its significantly adverse impact on prognosis and quality of life. Due to the impact of frailty on both prognosis and treatment of HF patients, all patients with HF, regardless of their chronological age, should be evaluated for the presence of, or the risk for developing frailty. However, although several instruments are available, there is still no consensus as to which is the best method to assess frailty in patients with HF. Therefore, a validated and easy to apply instrument to assess frailty in HF patients in daily practice is warranted.
No takes yet. Share an insight, caveat, or question.
Vitale et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: